Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-May-24 6:55 PM View:  | Nevro Corp (NVRO) | 23-May-24 | Grant | 19,169 | -- | -- | 130% 14.78K to 33.95K | |
| 14-May-24 5:04 PM View: | AtriCure, Inc. (ATRC) | 13-May-24 | Grant | 7,788 | -- | -- | 48% 16.14K to 23.93K | |
| 09-Feb-24 6:08 PM View: | Embecta Corp. (EMBC) | 07-Feb-24 | Grant | 11,455 | -- | -- | 85% 13.44K to 24.9K | |
| 21-Jul-23 4:02 PM View: | Viewray, Inc. (VRAY) | 21-Jul-23 | Sale | 37,600 | $0.05 | $1,917.60 | (81%) 46.4K to 8.8K | |
| 21-Jul-23 4:02 PM View: | Viewray, Inc. (VRAY) | 19-Jul-23 | Sale | 91,866 | $0.08 | $6,889.95 | (66%) 138.26K to 46.4K | |
| 12-Jun-23 8:59 AM View: | AtriCure, Inc. (ATRC) | 08-Jun-23 | Sale | 713 | $47.89 | $34,145.60 | (4%) 16.85K to 16.14K | |
| 26-May-23 4:25 PM View: | AtriCure, Inc. (ATRC) | 25-May-23 | Grant | 3,186 | -- | -- | 23% 13.67K to 16.85K | |
| 30-May-23 5:15 PM View: | Nevro Corp (NVRO) | 25-May-23 | Grant | 6,754 | -- | -- | 84% 8.03K to 14.78K | |
| 10-Feb-23 4:09 PM View: | Embecta Corp. (EMBC) | 09-Feb-23 | Grant | 6,979 | -- | -- | 115% 6.09K to 13.07K | |
| 15-Jun-22 4:09 PM View: | Viewray, Inc. (VRAY) | 13-Jun-22 | Grant | 54,511 | -- | -- | 65% 83.75K to 138.26K | |
| 27-May-22 8:59 PM View: | Nevro Corp (NVRO) | 26-May-22 | Grant | 4,155 | -- | -- | 107% 3.87K to 8.03K | |
| 27-May-22 9:03 AM View: | AtriCure, Inc. (ATRC) | 25-May-22 | Grant | 3,564 | -- | -- | 35% 10.1K to 13.67K | |
| 12-May-22 6:05 AM View: | Viewray, Inc. (VRAY) | 10-May-22 | Private Purchase | 37,600 | $2.66 | $100,002.00 | 81% 46.15K to 83.75K | |
| 05-Apr-22 5:38 PM View: | Embecta Corp. (EMBC) | 01-Apr-22 | Grant | 6,024 | -- | -- | 100% 0 to 6.02K | |
| 06-Jul-21 10:00 PM View: | Viewray, Inc. (VRAY) | 01-Jul-21 | Grant | 26,395 | -- | -- | 134% 19.76K to 46.15K | |
| 16-Jun-21 4:25 PM View: | Viewray, Inc. (VRAY) | 14-Jun-21 | Grant | 19,759 | -- | -- | 100% 0 to 19.76K | |
| 02-Jun-21 5:27 PM View: | Cantel Medical Corp. (CMD) | 02-Jun-21 | Disposition | 1,935 | $80.59 | $155,942.00 | (100%) 1.94K to 0 | < 1% |
| 26-May-21 9:01 PM View: | Nevro Corp (NVRO) | 25-May-21 | Grant | 1,167 | -- | -- | 43% 2.7K to 3.87K | |
| 24-May-21 4:52 PM View: | AtriCure, Inc. (ATRC) | 20-May-21 | Grant | 1,749 | -- | -- | 21% 8.35K to 10.1K | |
| 31-Jul-20 5:53 PM View: | Cantel Medical Corp. (CMD) | 31-Jul-20 | Grant | 1,935 | -- | -- | 100% 0 to 1.94K | |
| 22-May-20 8:28 AM View: | AtriCure, Inc. (ATRC) | 20-May-20 | Grant | 2,452 | -- | -- | 42% 5.9K to 8.35K | |
| 18-Dec-19 4:31 PM View: | Nevro Corp (NVRO) | 17-Dec-19 | Grant | 2,703 | -- | -- | 100% 0 to 2.7K | |
| 05-Dec-19 4:24 PM View: | AtriCure, Inc. (ATRC) | 04-Dec-19 | Grant | 5,902 | -- | -- | 100% 0 to 5.9K | |
| 06-Mar-18 4:23 PM View: | Henry Schein Inc. (HSIC) | 02-Mar-18 | Grant | 19,558 | -- | -- | 45% 43.34K to 62.9K | |
| 08-Mar-17 4:25 PM View: | Henry Schein Inc. (HSIC) | 06-Mar-17 | Grant | 8,777 | -- | -- | 68% 12.89K to 21.67K | |
| 14-Jun-16 4:20 PM View: | Henry Schein Inc. (HSIC) | 10-Jun-16 | Grant | 12,895 | -- | -- | 100% 0 to 12.89K | |
| 08-Mar-16 4:13 PM View: | Boston Scientific Corp. (BSX) | 08-Mar-16 | Market Sale (Planned) | 14,747 | $17.27 | $254,749.00 | (27%) 54.14K to 39.4K | (99%) |
| 01-Mar-16 4:35 PM View: | Boston Scientific Corp. (BSX) | 28-Feb-16 | Payment of Exercise | 1,753 | $17.21 | $30,169.10 | (3%) 55.9K to 54.14K | (100%) |
| 01-Mar-16 4:35 PM View: | Boston Scientific Corp. (BSX) | 28-Feb-16 | Option Exercise | 3,721 | -- | -- | 7% 52.17K to 55.9K | |
| 26-Feb-16 10:00 PM View: | Boston Scientific Corp. (BSX) | 24-Feb-16 | Payment of Exercise | 991 | $17.33 | $17,174.00 | (2%) 53.16K to 52.17K | (98%) |
| 26-Feb-16 10:00 PM View: | Boston Scientific Corp. (BSX) | 24-Feb-16 | Option Exercise | 2,102 | -- | -- | 4% 51.06K to 53.16K | |
| 25-Feb-16 4:34 PM View: | Boston Scientific Corp. (BSX) | 23-Feb-16 | Payment of Exercise | 1,001 | $17.24 | $17,257.20 | (2%) 52.06K to 51.06K | (99%) |
| 25-Feb-16 4:34 PM View: | Boston Scientific Corp. (BSX) | 23-Feb-16 | Option Exercise | 2,299 | -- | -- | 5% 49.77K to 52.06K | |
| 24-Feb-16 4:50 PM View: | Boston Scientific Corp. (BSX) | 22-Feb-16 | Grant | 37,212 | -- | -- | 151% 24.65K to 61.86K | |
| 24-Feb-16 4:50 PM View: | Boston Scientific Corp. (BSX) | 22-Feb-16 | Payment of Exercise | 12,094 | $17.26 | $208,742.00 | (20%) 61.86K to 49.77K | (99%) |
| 09-Feb-16 4:06 PM View: | Boston Scientific Corp. (BSX) | 08-Feb-16 | Market Sale | 6,216 | $16.05 | $99,785.40 | (20%) 30.86K to 24.65K | (114%) |
| 05-Jan-16 4:11 PM View: | Boston Scientific Corp. (BSX) | 01-Jan-16 | Payment of Exercise | 6,433 | $18.44 | $118,625.00 | (17%) 37.3K to 30.86K | (86%) |
| 05-Jan-16 4:11 PM View: | Boston Scientific Corp. (BSX) | 01-Jan-16 | Option Exercise | 18,866 | -- | -- | 102% 18.43K to 37.3K | |
| 07-Jul-15 4:08 PM View: | Boston Scientific Corp. (BSX) | 07-Jul-15 | Market Sale (Planned) | 17,456 | $17.66 | $308,308.00 | (49%) 35.89K to 18.43K | (95%) |
| 06-Jul-15 4:32 PM View: | Boston Scientific Corp. (BSX) | 02-Jul-15 | Payment of Exercise | 8,406 | $17.57 | $147,693.00 | (19%) 44.29K to 35.89K | (96%) |
| 06-Jul-15 4:32 PM View: | Boston Scientific Corp. (BSX) | 02-Jul-15 | Option Exercise | 25,862 | -- | -- | 140% 18.43K to 44.29K | |
| 04-Mar-15 4:17 PM View: | Boston Scientific Corp. (BSX) | 03-Mar-15 | Market Sale (Planned) | 2,492 | $16.79 | $41,837.70 | (12%) 20.92K to 18.43K | (105%) |
| 03-Mar-15 5:17 PM View: | Boston Scientific Corp. (BSX) | 28-Feb-15 | Payment of Exercise | 1,229 | $16.90 | $20,770.10 | (6%) 22.15K to 20.92K | (103%) |
| 03-Mar-15 5:17 PM View: | Boston Scientific Corp. (BSX) | 28-Feb-15 | Option Exercise | 3,721 | -- | -- | 20% 18.43K to 22.15K | |
| 02-Mar-15 4:13 PM View: | Boston Scientific Corp. (BSX) | 27-Feb-15 | Market Sale (Planned) | 1,307 | $16.80 | $21,963.20 | (7%) 19.74K to 18.43K | (104%) |
| 26-Feb-15 4:05 PM View: | Boston Scientific Corp. (BSX) | 24-Feb-15 | Payment of Exercise | 795 | $16.62 | $13,212.90 | (4%) 20.53K to 19.74K | (107%) |
| 26-Feb-15 4:05 PM View: | Boston Scientific Corp. (BSX) | 24-Feb-15 | Option Exercise | 2,102 | -- | -- | 11% 18.43K to 20.53K | |
| 10-Dec-14 4:10 PM View: | Boston Scientific Corp. (BSX) | 10-Dec-14 | Market Sale (Planned) | 19,753 | $12.64 | $249,607.00 | (52%) 38.18K to 18.43K | (172%) |
| 07-Jul-14 4:06 PM View: | Boston Scientific Corp. (BSX) | 02-Jul-14 | Payment of Exercise | 8,419 | $13.13 | $110,541.00 | (18%) 46.6K to 38.18K | (162%) |
| 07-Jul-14 4:06 PM View: | Boston Scientific Corp. (BSX) | 02-Jul-14 | Option Exercise | 25,862 | -- | -- | 125% 20.74K to 46.6K |